[BGLC] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
31-May-2024
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -103.90%
YoY- -276.40%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 2,554 2,567 2,377 2,840 2,575 2,485 3,029 -10.73%
PBT -2,532 -275 -53 -127 -67 -140 31 -
Tax 76 -16 16 30 10 -2 14 208.56%
NP -2,608 -259 -69 -157 -77 -139 17 -
Tax Rate - - - - - - -45.59% -
Total Cost 5,162 2,826 2,446 2,997 2,652 2,624 3,012 43.16%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -102.13 -10.10 -2.91 -5.53 -3.01 -5.58 0.56 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.16 -0.02 -0.00 -0.01 -0.01 -0.01 0.00 -
EPS Diluted -0.16 -0.02 -0.00 -0.01 -0.01 -0.01 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.